Research and Development Based on Proprietary Technology and Product Planning Capabilities
First written in FY2016-Q2. 23 of 28 entries say "Restated". Latest entry: FY2025.
54 other companies' latest entry also says "Advanced".
- FY2025AdvancedAnnual report
「The Group's R&D expenses for the fiscal year were ¥1,112 million. R&D activities in its principal segments were as follows.」
R&D expenses totaled ¥1,112 million. Research progressed on circular uniform materials, environmentally friendly materials, medical and high-performance materials, digital twins, new devices, and unused energy. - FY2024-Q2RestatedAnnual report
「The Group's R&D expenses for the cumulative second quarter were ¥463 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」
R&D expenses of ¥463 million were disclosed, with no material changes in R&D activities reported. - FY2024-Q1RestatedAnnual report
「The Group's R&D expenses for the cumulative first quarter were ¥226 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter.」
R&D expenses of ¥226 million were disclosed, with no material changes in R&D activities reported. - FY2023AdvancedAnnual report
「The Group's R&D expenses for the fiscal year were ¥901 million. R&D activities in its principal segments were as follows.」
Annual R&D expenses of ¥901 million were recorded. Work progressed on circular uniform materials, materials using recycled polyester, medical, high-performance and environmentally friendly materials, automated textile inspection technology, and CO2 reduction measures. The report also noted regulatory approval for the bioabsorbable sheet "Ｐａｗｄｒｅ." - FY2023-Q3RestatedAnnual report
「The Group's R&D expenses for the cumulative third quarter were ¥628 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」
R&D expenses of ¥628 million were disclosed, with no material changes in R&D activities reported. - FY2023-Q2RestatedAnnual report
「The group's research and development expenses for the six-month cumulative period ended in the second quarter were ¥414 million. There were no material changes in the status of the group's research and development activities during the six-month cumulative period ended in the second quarter.」
R&D expenses of ¥414 million were disclosed for the cumulative second-quarter period, with no material changes in R&D activities reported. - FY2023-Q1RestatedAnnual report
「The group's research and development expenses for the three-month cumulative period ended in the first quarter were ¥189 million. There were no material changes in the status of the group's research and development activities during the three-month cumulative period ended in the first quarter.」
The company disclosed research and development expenses of ¥189 million and stated that there were no material changes in research and development activities. - FY2022-Q3RestatedAnnual report
「The group's research and development expenses for the nine-month cumulative period ended in the third quarter were ¥636 million. There were no material changes in the status of the group's research and development activities during the nine-month cumulative period ended in the third quarter.」
The company disclosed research and development expenses of ¥636 million and stated that there were no material changes in research and development activities. - FY2022-Q1RestatedAnnual report
「The group's research and development expenses for the three-month cumulative period ended in the first quarter were ¥211 million. There were no material changes in the status of the group's research and development activities during the three-month cumulative period ended in the first quarter.」
The company disclosed research and development expenses of ¥211 million for the three-month cumulative period ended in the first quarter and stated that there were no material changes in research and development activities. - FY2021RestatedAnnual report
「The group's research and development expenses for the fiscal year were ¥922 million, and its principal segments' research and development activities were as follows.」
The company disclosed research and development expenses of ¥922 million and continued research into low-fuzz wool yarn, recycled-polyester materials, medical materials, high-performance materials, environmentally friendly materials, IoT, care equipment and CO2 reduction measures, among other areas. - FY2021-Q3RestatedAnnual report
「The group's research and development expenses for the nine-month cumulative period ended in the third quarter were ¥657 million. There were no material changes in the status of the group's research and development activities during the nine-month cumulative period ended in the third quarter.」
The company disclosed research and development expenses of ¥657 million for the nine-month cumulative period ended in the third quarter and stated that there were no material changes in research and development activities. - FY2021-Q1RestatedAnnual report
「The group's research and development expenses for the three-month cumulative period ended in the first quarter were ¥165 million. There were no material changes in the status of the group's research and development activities during the three-month cumulative period ended in the first quarter.」
The company disclosed research and development expenses of ¥165 million for the three-month cumulative period ended in the first quarter and stated that there were no material changes in research and development activities. - FY2020-Q3RestatedAnnual report
「The group's research and development expenses for the nine-month cumulative period ended in the third quarter were ¥665 million. There were no material changes in the status of the group's research and development activities during the nine-month cumulative period ended in the third quarter.」
The company disclosed research and development expenses of ¥665 million for the nine-month cumulative period ended in the third quarter and stated that there were no material changes in research and development activities. - FY2020-Q2RestatedAnnual report
「The group's research and development expenses for the six-month cumulative period ended in the second quarter were ¥457 million. There were no material changes in the status of the group's research and development activities during the six-month cumulative period ended in the second quarter.」
The company disclosed research and development expenses of ¥457 million for the six-month cumulative period ended in the second quarter and stated that there were no material changes in research and development activities. - FY2020-Q1RestatedAnnual report
「The group's research and development expenses for the three-month cumulative period ended in the first quarter were ¥213 million. There were no material changes in the status of the group's research and development activities during the three-month cumulative period ended in the first quarter.」
The company disclosed research and development expenses of ¥213 million for the three-month cumulative period ended in the first quarter and stated that there were no material changes in research and development activities. - FY2019AdvancedAnnual report
「The group's research and development expenses for the fiscal year were ¥903 million, and its principal segments' research and development activities were as follows.」
The company disclosed annual research and development expenses of ¥903 million and continued developing low-fuzz wool yarn and fabrics, cut-resistant fabrics and panels, environmentally friendly wool fabrics using plant-based and recycled polyester, medical materials, high-performance fibers, bio-agriculture, IoT and care equipment, among other products and technologies. - FY2019-Q3RestatedAnnual report
「The group's research and development expenses for the nine-month cumulative period ended in the third quarter were ¥684 million. There were no material changes in the status of the group's research and development activities during the nine-month cumulative period ended in the third quarter.」
The company disclosed research and development expenses of ¥684 million for the nine-month cumulative period ended in the third quarter and stated that there were no material changes in research and development activities. - FY2019-Q2RestatedAnnual report
「The group's research and development expenses for the six-month cumulative period ended in the second quarter were ¥468 million. There were no material changes in the status of the group's research and development activities during the six-month cumulative period ended in the second quarter.」
The company disclosed research and development expenses of ¥468 million for the six-month cumulative period ended in the second quarter and stated that there were no material changes in research and development activities. - FY2019-Q1RestatedAnnual report
「The group's research and development expenses for the three-month cumulative period ended in the first quarter were ¥237 million. There were no material changes in the status of the group's research and development activities during the three-month cumulative period ended in the first quarter.」
The company disclosed research and development expenses of ¥237 million for the three-month cumulative period ended in the first quarter and stated that there were no material changes in research and development activities. - FY2018AdvancedAnnual report
「The group's research and development expenses for the fiscal year were ¥916 million, and its principal segments' research and development activities were as follows.」
The company disclosed research and development expenses of ¥916 million and advanced research into fire-resistant clothing, cut-resistant fabrics, high-performance fibers, medical materials, bio-agriculture, IoT and care equipment, among other areas. It also began commercializing and selling Genocel, a gelatin cell-culture scaffold material. - FY2018-Q3RestatedAnnual report
「The group's research and development expenses for the nine-month cumulative period ended in the third quarter were ¥694 million. There were no material changes in the status of the group's research and development activities during the nine-month cumulative period ended in the third quarter.」
The company disclosed research and development expenses of ¥694 million for the nine-month cumulative period ended in the third quarter and stated that there were no material changes in research and development activities. - FY2018-Q2RestatedAnnual report
「The group's research and development expenses for the six-month cumulative period ended in the second quarter were ¥469 million. There were no material changes in the status of the group's research and development activities during the six-month cumulative period ended in the second quarter.」
The company disclosed research and development expenses of ¥469 million and stated that there were no material changes in research and development activities. - FY2018-Q1RestatedAnnual report
「The group's research and development expenses for the three-month cumulative period ended in the first quarter were ¥215 million. There were no material changes in the status of the group's research and development activities during the three-month cumulative period ended in the first quarter.」
The company disclosed research and development expenses of ¥215 million and stated that there were no material changes in research and development activities. - FY2017-Q3RestatedAnnual report
「The group's research and development expenses for the nine-month cumulative period ended in the third quarter were ¥647 million. There were no material changes in the status of the group's research and development activities during the nine-month cumulative period ended in the third quarter.」
The company disclosed research and development expenses of ¥647 million and stated that there were no material changes in research and development activities. - FY2017-Q2RestatedAnnual report
「The group's research and development expenses for the six-month cumulative period ended in the second quarter were ¥421 million. There were no material changes in the status of the group's research and development activities during the six-month cumulative period ended in the second quarter.」
The company disclosed research and development expenses of ¥421 million and stated that there were no material changes in research and development activities. - FY2017-Q1RestatedAnnual report
「The group's research and development expenses for the three-month cumulative period ended in the first quarter were ¥198 million. There were no material changes in the status of the group's research and development activities during the three-month cumulative period ended in the first quarter.」
The company disclosed research and development expenses of ¥198 million and stated that there were no material changes in research and development activities. - FY2016-Q3RestatedAnnual report
「The group's research and development expenses for the nine-month cumulative period ended in the third quarter were ¥509 million. There were no material changes in the status of the group's research and development activities during the nine-month cumulative period ended in the third quarter.」
The company disclosed research and development expenses of ¥509 million and stated that there were no material changes in research and development activities. - FY2016-Q2First statedAnnual report
「The group's research and development expenses for the six-month period ended [the current second quarter] were ¥321 million. There were no material changes in the group's research and development activities during the period.」
R&D expenses for the six-month period were ¥321 million, and there were no material changes in R&D activities.